S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Calyxt Stock Forecast, Price & News

-0.11 (-3.44%)
(As of 11/26/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
34,170 shs
Average Volume
264,456 shs
Market Capitalization
$118.98 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive CLXT News and Ratings via Email

Sign-up to receive the latest news and ratings for Calyxt and its competitors with MarketBeat's FREE daily newsletter.

Calyxt logo

About Calyxt

Calyxt, Inc. is technology company, which engages in delivering plant-based solutions. Its products include high oleic soybean oil, high fiber wheat, high oleic soybean meal, and low lignin alfalfa. The company was founded by Daniel F. Voytas and André Choulika on January 8, 2010 and is headquartered in Roseville, MN.


See More Headlines

Industry, Sector and Symbol

Agricultural chemicals
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$23.85 million
Book Value
$0.41 per share


Net Income
$-44.84 million
Pretax Margin




Free Float
Market Cap
$118.98 million
Not Optionable

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

2.04 out of 5 stars

Consumer Staples Sector

98th out of 185 stocks

Agricultural Chemicals Industry

8th out of 14 stocks

Analyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Calyxt (NASDAQ:CLXT) Frequently Asked Questions

Is Calyxt a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Calyxt in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Calyxt stock.
View analyst ratings for Calyxt
or view top-rated stocks.

How has Calyxt's stock been impacted by Coronavirus (COVID-19)?

Calyxt's stock was trading at $3.34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CLXT shares have decreased by 7.5% and is now trading at $3.09.
View which stocks have been most impacted by COVID-19

Are investors shorting Calyxt?

Calyxt saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 430,200 shares, a drop of 39.5% from the October 31st total of 711,300 shares. Based on an average trading volume of 292,900 shares, the days-to-cover ratio is currently 1.5 days. Currently, 3.2% of the shares of the stock are sold short.
View Calyxt's Short Interest

When is Calyxt's next earnings date?

Calyxt is scheduled to release its next quarterly earnings announcement on Thursday, March 3rd 2022.
View our earnings forecast for Calyxt

How were Calyxt's earnings last quarter?

Calyxt, Inc. (NASDAQ:CLXT) announced its quarterly earnings data on Thursday, November, 4th. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.19) by $0.05. Calyxt had a negative trailing twelve-month return on equity of 149.78% and a negative net margin of 93.59%. During the same period in the previous year, the business earned ($0.28) earnings per share.
View Calyxt's earnings history

What price target have analysts set for CLXT?

4 equities research analysts have issued twelve-month price objectives for Calyxt's stock. Their forecasts range from $7.00 to $10.00. On average, they anticipate Calyxt's share price to reach $9.00 in the next twelve months. This suggests a possible upside of 191.3% from the stock's current price.
View analysts' price targets for Calyxt
or view top-rated stocks among Wall Street analysts.

Who are Calyxt's key executives?

Calyxt's management team includes the following people:

What other stocks do shareholders of Calyxt own?

When did Calyxt IPO?

(CLXT) raised $101 million in an initial public offering on Thursday, July 20th 2017. The company issued 6,100,000 shares at a price of $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities served as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

What is Calyxt's stock symbol?

Calyxt trades on the NASDAQ under the ticker symbol "CLXT."

Who are Calyxt's major shareholders?

Calyxt's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Nikko Asset Management Americas Inc. (5.01%), Sumitomo Mitsui Trust Holdings Inc. (5.18%), Uniplan Investment Counsel Inc. (1.35%), Morgan Stanley (0.48%), Two Sigma Advisers LP (0.34%) and Renaissance Technologies LLC (0.27%). Company insiders that own Calyxt stock include Andre Choulika, Anna Ewa Kozicz-Stankiewicz, Christopher J Neugent, Daniel F Voytas, James Blome, Michael A Carr, Philippe Dumont, Travis Frey, William Koschak and Yves J Ribeill.
View institutional ownership trends for Calyxt

Which major investors are selling Calyxt stock?

CLXT stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Nikko Asset Management Americas Inc., Renaissance Technologies LLC, Morgan Stanley, Goldman Sachs Group Inc., Oppenheimer & Co. Inc., and Uniplan Investment Counsel Inc.. Company insiders that have sold Calyxt company stock in the last year include Daniel F Voytas, and James Blome.
View insider buying and selling activity for Calyxt
or view top insider-selling stocks.

Which major investors are buying Calyxt stock?

CLXT stock was purchased by a variety of institutional investors in the last quarter, including Two Sigma Advisers LP, Two Sigma Investments LP, Bank of New York Mellon Corp, KBC Group NV, Marshall Wace LLP, Connor Clark & Lunn Investment Management Ltd., and First Manhattan Co.. Company insiders that have bought Calyxt stock in the last two years include Christopher J Neugent, Michael A Carr, Philippe Dumont, Travis Frey, and William Koschak.
View insider buying and selling activity for Calyxt
or or view top insider-buying stocks.

How do I buy shares of Calyxt?

Shares of CLXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Calyxt's stock price today?

One share of CLXT stock can currently be purchased for approximately $3.09.

How much money does Calyxt make?

Calyxt has a market capitalization of $118.98 million and generates $23.85 million in revenue each year. The company earns $-44.84 million in net income (profit) each year or ($0.97) on an earnings per share basis.

How many employees does Calyxt have?

Calyxt employs 59 workers across the globe.

What is Calyxt's official website?

The official website for Calyxt is www.calyxt.com.

Where are Calyxt's headquarters?

Calyxt is headquartered at 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113.

How can I contact Calyxt?

Calyxt's mailing address is 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113. The company can be reached via phone at (651) 683-2807 or via email at [email protected].

This page was last updated on 11/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.